272 related articles for article (PubMed ID: 25943556)
1. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.
Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S;
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556
[TBL] [Abstract][Full Text] [Related]
2. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
4. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
5. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
[TBL] [Abstract][Full Text] [Related]
6. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
7. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
[TBL] [Abstract][Full Text] [Related]
8. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
Leto L; Testa M; Feola M
Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
[TBL] [Abstract][Full Text] [Related]
10. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
[TBL] [Abstract][Full Text] [Related]
12. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
13. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
[TBL] [Abstract][Full Text] [Related]
14. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure.
Carubelli V; Lombardi C; Lazzarini V; Bonadei I; Castrini AI; Gorga E; Richards AM; Metra M
J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):828-39. PubMed ID: 27322401
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
18. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
[TBL] [Abstract][Full Text] [Related]
19. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
Gaggin HK; Truong QA; Rehman SU; Mohammed AA; Bhardwaj A; Parks KA; Sullivan DA; Chen-Tournoux A; Moore SA; Richards AM; Troughton RW; Lainchbury JG; Weiner RB; Baggish AL; Semigran MJ; Januzzi JL
Congest Heart Fail; 2013; 19(3):135-42. PubMed ID: 23279139
[TBL] [Abstract][Full Text] [Related]
20. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
